Maynard Um
-
-
-
-
-
-
-
Stifel Reiterates Hold Rating on BioMarin Pharmaceutical Inc. (BMRN)
-
-
-
-
-
-
-
BioMarin Pharma (BMRN) Tops Q2 EPS by 25c
-
-
-
-
-
-
-
BioMarin shares VOXZOGO three-year data and BMN 333 Phase 1 results
-
-
-
-
-
-
-
BioMarin Pharmaceutical Inc. (BMRN) PT Raised to $120 at Evercore ISI
-
-
-
-
-
-
-
BioMarin reports early VOXZOGO treatment benefits for achondroplasia
-
-
-
-
-
-
-
BioMarin Pharmaceutical Inc. (BMRN) PT Raised to $104 at Canaccord
-
-
-
-
-
-
-
Canaccord Genuity Upgrades BioMarin Pharmaceutical Inc. (BMRN) to Buy
-
443,671 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

